(Q48653812)

English

A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety.

scientific article published on 27 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

A Novel Way To Radiolabel Human Butyrylcholinesterase for Positron Emission Tomography through Irreversible Transfer of the Radiolabeled Moiety. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

positron emission tomography

1 reference

based on heuristic

inferred from title

Takahiro Higuchi

4

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

author name string

Edgar Sawatzky

1

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Ehab Al-Momani

2

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Ryohei Kobayashi

3

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Samuel Samnick

5

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Michael Decker

6

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

publication date

27 June 2016

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

11

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

14

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

1540-1550

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Cholinergic system during the progression of Alzheimer's disease: therapeutic implications

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

The cholinergic system and Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

The cholinergic system in aging and neuronal degeneration

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Cholinergic function and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Neurobiology of butyrylcholinesterase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase inhibitors ameliorate cognitive dysfunction induced by amyloid-β peptide in mice.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase radioligands to image Alzheimer's disease brain.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Serum butyrylcholinesterase is strongly associated with adiposity, the serum lipid profile and insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Serum butyrylcholinesterase and the risk of future type 2 diabetes: the Kansai Healthcare Study.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase activity in young men and women: association with cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Butyrylcholinesterase activity and risk factors for coronary artery disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

PET probes for imaging brain acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Cholinergic system function and cognition in mild cognitive impairment.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Binding of 2-[18F]fluoro-CP-118,954 to mouse acetylcholinesterase: microPET and ex vivo Cerenkov luminescence imaging studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and evaluation of 2-[18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and evaluation of (-)- and (+)-[¹¹C]galanthamine as PET tracers for cerebral acetylcholinesterase imaging

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Pharmacological evaluation of [11C]donepezil as a tracer for visualization of acetylcholinesterase by PET.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Positron emission tomography study of [11C]methyl-tetrahydroaminoacridine (methyl-tacrine) in baboon brain.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A novel fluorine-18 β-fluoroethoxy organophosphate positron emission tomography imaging tracer targeted to central nervous system acetylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Quantitative measurement of cerebral acetylcholinesterase using

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Development of a novel fluorine-18 labeled deuterated fluororasagiline ([(18)F]fluororasagiline-D2) radioligand for PET studies of monoamino oxidase B (MAO-B).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and evaluation of [¹⁸F]fluororasagiline, a novel positron emission tomography (PET) radioligand for monoamine oxidase B (MAO-B).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

In Vivo and In Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18F-Labeled Deuterated Fluorodeprenyl.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiosynthesis and ex vivo evaluation of [(11)C-carbonyl]carbamate- and urea-based monoacylglycerol lipase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Mapping human brain fatty acid amide hydrolase activity with PET.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

[11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

PET imaging of fatty acid amide hydrolase with [(18)F]DOPP in nonhuman primates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiosynthesis and evaluation of [¹¹C-carbonyl]-labeled carbamates as fatty acid amide hydrolase radiotracers for positron emission tomography.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Monoamine oxidase: radiotracer development and human studies

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP).

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Age-related increases in brain monoamine oxidase B in living healthy human subjects.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Reproducibility of repeated measures of deuterium substituted [11C]L-deprenyl ([11C]L-deprenyl-D2) binding in the human brain.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Discovery of Highly Selective and Nanomolar Carbamate-Based Butyrylcholinesterase Inhibitors by Rational Investigation into Their Inhibition Mode

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Neuroprotective Tri- and Tetracyclic BChE Inhibitors Releasing Reversible Inhibitors upon Carbamate Transfer

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Development and characterization of a promising fluorine-18 labelled radiopharmaceutical for in vivo imaging of fatty acid amide hydrolase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and preclinical evaluation of [11C-carbonyl]PF-04457845 for neuroimaging of fatty acid amide hydrolase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

11CO2 fixation: a renaissance in PET radiochemistry.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Synthesis and application of isocyanates radiolabeled with carbon-11.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Carbamates with differential mechanism of inhibition toward acetylcholinesterase and butyrylcholinesterase.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Organic carbamates in drug design and medicinal chemistry

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Irreversible inhibitors of serine, cysteine, and threonine proteases

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

Molecular Recognition by Cholesterol Esterase of Active Site Ligands: Structure−Reactivity Effects for Inhibition by Aryl Carbamates and Subsequent Carbamylenzyme Turnover†

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

21 January 2018

A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of rivastigmine and donepezil on brain acetylcholine levels in acetylcholinesterase-deficient mice.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

The butyrylcholinesterase knockout mouse is obese on a high-fat diet

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthesis and preliminary evaluation of piperidinyl and pyrrolidinyl iodobenzoates as imaging agents for butyrylcholinesterase

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

One-pot synthesis of [11C]ureas via triphenylphosphinimines

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201600223

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CMDC.201600223

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 February 2018

http://europepmc.org/abstract/MED/27348083

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48653812&oldid=1513827147"